Leerink Partners analyst Mike Kratky initiates coverage on Zimmer Biomet (NYSE: ZBH) with a Market Perform rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage